AQA
CORT icon

Alpha Quant Advisors’s Corcept Therapeutics CORT Stock Holding History

Alpha Quant Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$9K Hold
799
– – 0.01% 259
2018
Q4 		$11K Buy
+799
New +$10.6K 0.01% 243

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alpha Quant Advisors's CORT Position: Q1 2019 in Review

Alpha Quant Advisors held its Corcept Therapeutics (CORT) position steady in Q1 2019 at 799 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #259.

Alpha Quant Advisors first reported a position in CORT in Q4 2018 and has held it in 2 quarters since. The position peaked at $11K in Q4 2018. 208 funds tracked by Wall St. Rank hold CORT as of Q1 2019.

  • Alpha Quant Advisors held 799 shares of Corcept Therapeutics worth $9K as of Q1 2019.
  • Alpha Quant Advisors left its Corcept Therapeutics share count unchanged in Q1 2019.
  • Corcept Therapeutics made up 0.01% of Alpha Quant Advisors's portfolio in Q1 2019, its #259 holding.
  • Alpha Quant Advisors first reported a position in Corcept Therapeutics in Q4 2018 and has held it in 2 quarters since.
  • Alpha Quant Advisors's Corcept Therapeutics position peaked at $11K in Q4 2018.
  • 208 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.